0000014272-15-000183.txt : 20150515 0000014272-15-000183.hdr.sgml : 20150515 20150515165741 ACCESSION NUMBER: 0000014272-15-000183 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150505 FILED AS OF DATE: 20150515 DATE AS OF CHANGE: 20150515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gordon Murdo CENTRAL INDEX KEY: 0001642156 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 15870582 MAIL ADDRESS: STREET 1: C/O BRISTOL-MYERS SQUIBB COMPANY STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 3 1 wf-form3_143172345046220.xml FORM 3 X0206 3 2015-05-05 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001642156 Gordon Murdo BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 SVP, Head of Worldwide Markets Common Stock, $0.10 par value 205 D Market Share Units 2016-03-06 Common Stock, $0.10 par value 1282.0 D Market Share Units 2017-03-10 Common Stock, $0.10 par value 3060.0 D Market Share Units 2018-03-10 Common Stock, $0.10 par value 5514.0 D Market Share Units 2019-03-10 Common Stock, $0.10 par value 9822.0 D Performance Shares 2016-03-10 Common Stock, $0.10 par value 8095.32 D Performance Shares 2017-03-10 Common Stock, $0.10 par value 16695.7 D Restricted Stock Units 2016-07-01 Common Stock, $0.10 par value 4670.0 D Restricted Stock Units 2018-08-01 Common Stock, $0.10 par value 4531.0 D These market share units will vest on March 6, 2016. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. One-half of these market share units will vest on each of March 10, 2016 and March 10, 2017. One-third of these market share units will vest on each of March 10, 2016, March 10, 2017, and March 10, 2018. Twenty-five percent of these market share units will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 10, 2016. Consists of 7,739.66 performance shares and 355.66 performance shares representing dividend equivalents earned under the 2013-2015 Long-Term Performance Award. Each performance share converts into one share of common stock upon distribution in the first quarter of 2016. Each performance share converts into one share of common stock upon distribution in the first quarter of 2017, subject to a Total Shareholder Return modifier. One-half of these restricted stock units will vest on each of July 1, 2015 and July 1, 2016. Each restricted stock unit converts into one share of common stock upon vesting. The restricted stock units vest in three equal annual installments beginning on August 1, 2016. EXHIBIT LIST: Exhibit 24 - Murdo Gordon Power of Attorney /s/ Murdo Gordon 2015-05-15 EX-24 2 ex-24.htm EXHIBIT 24 - MURDO GORDON POWER OF ATTORNEY

POWER OF ATTORNEY

I, Murdo Gordon, Senior Vice President and Head of Worldwide Markets at Bristol-Myers Squibb Company (the "Company"),  a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sandra Leung, Katherine R. Kelly, and Robert J. Wollin, individually, as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934 with respect to securities issued by the Company, including, without limitation, the execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions.  This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4, and 5 with respect to securities issued by the Company, unless earlier revoked.

IN WITNESS WHEREOF, I have executed this Power of Attorney on this 11th day of May, 2015.


/s/ Murdo Gordon
Murdo Gordon